FDA.reportPublic FDA data

kisunla 350 MG in 20 ML Injection

RxCUI
2687979
RxNorm name
kisunla 350 MG in 20 ML Injection
Display name
kisunla 350 MG in 20 ML Injection
Full name
kisunla 350 MG in 20 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:48

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761248Kisunladonanemab-azbt351(a)Rx2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
KisunlaDONANEMAB-AZBTEli Lilly and Company190352d4-ef62-4679-b4fa-e846e2766afa2025-12-30Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2687979

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
190352d4-ef62-4679-b4fa-e846e2766afakisunla 350 MG in 20 ML Injection [PSN] · 20 ML donanemab-azbt 17.5 MG/ML Injection [Kisunla] [SBD] · Kisunla 350 MG per 20 ML Injection [SY]38These highlights do not include all the information needed to use KISUNLA safely and effectively. See full prescribing information for KISUNLA. KISUNLA (donanemab-azbt) injection, for intravenous use Initial U.S. Approval: 202420251230